Cart
sales@molnova.com
GSK3-IN-3
CAS No. 331963-27-0
GSK3-IN-3( —— )
Catalog No. M36514 CAS No. 331963-27-0
GSK3-IN-3 is a mitochondrial autophagy (mitophagy) inducer and GSK-3 inhibitor (IC50: 3.01 μM) that induces parkin-dependent mitochondrial autophagy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 52 | Get Quote |
|
| 5MG | 75 | Get Quote |
|
| 10MG | 132 | Get Quote |
|
| 25MG | 266 | Get Quote |
|
| 50MG | 419 | Get Quote |
|
| 100MG | 602 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK3-IN-3
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK3-IN-3 is a mitochondrial autophagy (mitophagy) inducer and GSK-3 inhibitor (IC50: 3.01 μM) that induces parkin-dependent mitochondrial autophagy.
-
DescriptionGSK3-IN-3 is a mitophagy inducer, inducing Parkin-dependent mitophagy. GSK3-IN-3 is also a GSK-3 inhibitor with an IC50 value of 3.01 μM. GSK3-IN-3 is non-ATP nor substrate competitive and is neuroprotective against 6-OHDA.
-
In VitroImmunofluorescenceCell Line:Parkin-expressing U2OS-iMLS cells Concentration:1.56 μM, 3.12 μM, 6.25 μM, 12.5 μM, and 25 μM; Incubation Time:24 hour sResult:Induced a mitochondrial morphology change from a filament-shaped network to a more round-shaped network.Cell Viability Assay Cell Line:SH-SY5Y cells Concentration:0.5 μM, 1 μM, 3 μM, 5 μM, and 10 μM Incubation Time:16 hours; with 35 μM 6-OHDA Result:Inhibited cell growth with an IC50 value of 2.57 μM.
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorMitophagy | GSK-3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number331963-27-0
-
Formula Weight429.55
-
Molecular FormulaC24H35N3O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 4.17 mg/mL (9.71 mM; Ultrasonic (<60°C)
-
SMILESC(C)N1C=2C(C(O)=C(C(NNC(CCCCCCCCCCC)=O)=O)C1=O)=CC=CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Maestro I, et al. Phenotypic Assay Leads to Discovery of Mitophagy Inducers with Therapeutic Potential for Parkinson's Disease. ACS Chem Neurosci. 2021 Dec 15;12(24):4512-4523. ?
molnova catalog
related products
-
CP21R7
A high-affinity, selective GSK3β inhibitor that activates canonical Wnt signaling.
-
VP3.15 dihydrobromid...
VP3.15 dihydrobromide is a potent orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE7- glycogen synthase kinase (GSK)3 inhibitor(with IC50s of 1.59 μM 0.88 μMrespectively.)
-
WAY-352753
WAY-352753 is a GSK3B-glycogen synthase kinase-3 beta inhibitor.
